ELGX - Endologix, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
136,274
143,370
156,473
181,157
192,925
Cost of revenue
53,255
52,284
64,550
59,828
69,133
Gross profit
83,019
91,086
91,923
121,329
123,792
Operating expenses
Research development
16,853
18,104
20,793
21,019
32,337
Selling general and administrative
99,070
100,657
120,332
127,701
148,803
Total operating expenses
129,339
132,797
154,976
161,672
197,355
Operating income or loss
-46,320
-41,711
-63,053
-40,343
-73,563
Interest expense
37,010
34,973
27,658
22,064
15,841
Total other income/expenses net
17,743
7,196
11,271
-4,535
-65,003
Income before tax
-65,581
-69,482
-79,430
-66,859
-154,179
Income tax expense
-4,736
-4,725
284
-459
498
Income from continuing operations
-60,845
-64,757
-79,714
-66,400
-154,677
Net income
-60,845
-64,757
-79,714
-66,400
-154,677
Net income available to common shareholders
-60,845
-64,757
-79,714
-66,400
-154,677
Basic EPS
-
-3.84
-9.10
-8.00
-19.10
Diluted EPS
-
-3.84
-9.10
-8.00
-19.10
Basic average shares
-
16,850
8,790
8,333
8,098
Diluted average shares
-
16,850
8,790
8,333
8,098
EBITDA
-
-27,619
-43,790
-35,684
-129,189